Can modafinil (provigil) increase blood pressure in patients, particularly those with pre-existing hypertension, depression, or anxiety?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Does Modafinil Increase Blood Pressure?

Yes, modafinil can increase blood pressure, though the effect is generally modest in most patients, with clinically significant increases occurring in fewer than 1% of patients. However, increased monitoring is essential in patients with pre-existing hypertension or cardiovascular disease, as a greater proportion of modafinil-treated patients require new or increased antihypertensive medications compared to placebo. 1

Cardiovascular Effects and Monitoring Requirements

Baseline and ongoing blood pressure monitoring is recommended before initiating modafinil and when adjusting doses, specifically assessing for hypertension, palpitations, or arrhythmias. 2 The FDA label emphasizes that while short-term controlled trials (≤3 months) showed no clinically significant changes in mean systolic and diastolic blood pressure compared to placebo, retrospective analysis revealed important differences in antihypertensive medication requirements. 1

Key Blood Pressure Data:

  • Clinically significant increases in diastolic blood pressure occurred in fewer than 1% of patients in pooled analysis of 1,529 patients 3
  • Only 1 patient had a clinically significant increase in heart rate in these studies 3
  • 2.4% of modafinil patients required new or increased antihypertensive medications versus 0.7% on placebo 1
  • In obstructive sleep apnea patients specifically, 3.4% required antihypertensive medication adjustments versus 1.1% on placebo 1

Contraindications and High-Risk Populations

Modafinil is contraindicated in patients with moderate to severe hypertension. 4 The FDA label specifically states that modafinil is not recommended in patients with:

  • History of left ventricular hypertrophy 1
  • Mitral valve prolapse who have experienced mitral valve prolapse syndrome when previously receiving CNS stimulants 1
  • Recent myocardial infarction or unstable angina (requires increased monitoring) 1

Cardiovascular Events Reported:

In clinical studies, cardiovascular adverse reactions including chest pain, palpitations, dyspnea, and transient ischemic T-wave changes on ECG occurred in three subjects with mitral valve prolapse or left ventricular hypertrophy. 1 One case involved a 35-year-old obese narcoleptic male who experienced a 9-second episode of asystole after 27 days of treatment. 1

Special Considerations for Patients with Depression and Anxiety

Caution should be exercised when prescribing modafinil to patients with a history of psychosis, depression, or mania. 1 While modafinil has shown preliminary evidence of benefit in treatment-resistant depression (mean dose 184.3 mg/day), with significant improvements on multiple depression rating scales at 2 weeks and 3 months 5, psychiatric adverse reactions can occur.

  • Psychiatric symptoms leading to discontinuation occurred more frequently with modafinil than placebo: anxiety (1%), nervousness (1%), insomnia (<1%), confusion (<1%), agitation (<1%), and depression (<1%) 1
  • Postmarketing reports include mania, delusions, hallucinations, and suicidal ideation 1

Common Adverse Effects

The most common adverse effects include:

  • Headache (34% vs 23% placebo) 3
  • Nausea (11% vs 3% placebo) 3
  • Nervousness and hypertension 6
  • Insomnia and anxiety 7

Clinical Monitoring Algorithm

For patients initiating modafinil:

  1. Measure baseline blood pressure and heart rate before starting treatment 2
  2. Screen for cardiovascular contraindications (left ventricular hypertrophy, mitral valve prolapse syndrome, recent MI, unstable angina) 1
  3. Assess psychiatric history (psychosis, depression, mania) 1
  4. Monitor blood pressure and heart rate more frequently when starting or adjusting doses 2, 1
  5. Question patients about excessive stimulatory effects at each visit 2
  6. Consider cardiac evaluation if new onset chest pain, arrhythmia, or ischemic ECG changes occur 1

For patients with pre-existing hypertension: Increased monitoring is appropriate, as these patients are more likely to require antihypertensive medication adjustments. 1 The blood pressure effects, while modest on average, can be clinically significant in vulnerable populations and warrant careful surveillance throughout treatment.

References

2
Guideline

Modafinil's Impact on Blood Pressure

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

3
Research

Evaluation of the safety of modafinil for treatment of excessive sleepiness.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2007

Related Questions

What are the considerations for using modafinil in patients with a history of sleep disorders, high blood pressure, heart disease, liver or kidney disease, or those taking medications like blood thinners or antidepressants?
What are the recommended dosing guidelines for modafinil in adults with narcolepsy or obstructive sleep apnea (OSA), for shift‑work sleep disorder, and how should the dose be adjusted for elderly patients or those with moderate hepatic or renal impairment?
Can modafinil (provigil) be crushed for a patient with difficulty swallowing?
Does modafinil (provigil) affect heart rate and blood pressure?
Is it appropriate to prescribe modafinil to a healthy 15‑year‑old adolescent for excessive daytime sleepiness?
Can a patient with diabetes (diabetes mellitus), peripheral neuropathy, and impaired renal function safely take gabapentin in combination with temazepam (Restoril, benzodiazepine)?
Can Mixed Connective Tissue Disease (MCTD) and Ehlers-Danlos syndrome cause a venous varix due to vascular compression or portal hypertension?
Why not use ideal body weight (IBW) in milligrams (mg) to calculate the dose of intravenous immunoglobulin (IVIG) for a patient with Guillain-Barré Syndrome, myasthenia gravis, and bronchial asthma?
What is the differential diagnosis for a female of reproductive age with a history of uterine fibroids (leiomyomas) experiencing severe vaginal bleeding for 30 days after a Depo-Provera (medroxyprogesterone acetate) injection?
What medication should be titrated down first in an older adult patient with hypothyroidism who is maxed out on Neomercazole (NEO) and also taking Levothyroxine (LEVO)?
When should Lokelma (sodium zirconium cyclosilicate) be given to a patient with hyperkalemia?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.